Ophthalmic Packaging Market by Material (Plastic, Glass, Metal), Product Type (Bottles, Vials & Ampoules, Tubes, Syringe), Dosage Form (Single-dose, Multi-dose), Application (Injectables, Eye Drops, Ointments & Gels), and Region - Global Forecast to 2030

icon1
USD 21.9 BN
MARKET SIZE, 2030
icon2
CAGR 15.5%
(2025-2030)
icon3
200
REPORT PAGES
icon4
130
MARKET TABLES

OVERVIEW

ophthalmic-packaging-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The ophthalmic packaging market is projected to reach USD 21.9 billion by 2030 from USD 10.6 billion in 2025, at a CAGR of 15.5% from 2025 to 2030. Ophthalmic packaging refers to specialized packaging solutions designed to protect and deliver eye care medications and treatments. These packaging systems are engineered to maintain sterility, prevent contamination, ensure precise dosing, and protect sensitive ophthalmic formulations from environmental factors. The market encompasses various packaging formats, including plastic bottles, vials, ampoules, and advanced delivery systems used for eye drops, ointments, injectables, and other ophthalmic pharmaceutical products.

KEY TAKEAWAYS

  • By Region
    The Asia Pacific region is expected to reach USD 7.3 billion by 2030, registering the highest CAGR of 18.0% during the forecast period, while North America and Europe are projected to grow at CAGRs of 15.0% and 14.5%, respectively.
  • By Material
    The plastic segment dominates the overall market due to its durability, cost-effectiveness, and wide applicability across various ophthalmic formulations.
  • By Application
    Injectables represent the largest segment due to their widespread use in vaccines and biologics requiring precise dosage and enhanced safety features.
  • By Segment
    Advanced polymers and eco-friendly materials are gaining significant traction as packaging companies invest in sustainable and innovative solutions to meet evolving regulatory and patient safety requirements.
  • Competitive Landscape - Star Players
    Amcor plc, Gerresheimer AG, and Schott AG were identified as leading players in the ophthalmic packaging market, given their strong market penetration, global presence, and extensive product portfolios focused on innovation and sustainability.
  • Competitive Landscape - Startups
    Emerging companies and specialized manufacturers have distinguished themselves by securing strong footholds in niche areas such as controlled release systems and specialized drug delivery solutions, underscoring their potential as future market leaders.

The ophthalmic packaging market is experiencing robust growth driven by advances in ophthalmic drug delivery systems, increasing prevalence of eye-related disorders due to the aging population, and significant research and development investments in innovative packaging techniques.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The ophthalmic packaging market is currently experiencing a phase of innovation and rapid adoption. Healthcare systems and pharmaceutical companies across North America, Europe, and Asia Pacific are witnessing advancements in packaging technology and regulatory frameworks. This progress aligns with emerging trends in personalized medicine, advanced drug delivery systems, and patient-centric packaging solutions. In the global market, the use of advanced polymers, specialized closure systems, and eco-friendly materials is increasing among pharmaceutical manufacturers and healthcare providers. These materials facilitate the development of packaging solutions that ensure product integrity, reduce contamination risks, and align with sustainability goals and patient safety requirements. Governments and regulatory bodies are encouraging innovation in anti-counterfeit technologies, the development of controlled release packaging systems, and collaborative research and development programs. These initiatives help shorten approval timelines and promote the adoption of technologically advanced, clinically validated packaging platforms tailored to the needs of diverse patient populations and therapeutic applications.

ophthalmic-packaging-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growing need for pharmaceutical packaging driven by chronic conditions and innovations in drug delivery
  • Rising global geriatric population increasing demand for effective ophthalmic treatments
RESTRAINTS
Impact
Level
  • High manufacturing costs due to stringent regulatory requirements and need for specialized materials
OPPORTUNITIES
Impact
Level
  • Expanding personalized medicine and growth in emerging markets
CHALLENGES
Impact
Level
  • Ensuring packaging supports anti-counterfeit measures through advanced technologies

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing need for pharmaceutical packaging driven by chronic conditions and innovations in drug delivery

The growing need for pharmaceutical packaging is being driven by the increasing prevalence of chronic eye conditions and continuous innovations in drug delivery systems. Enhanced patient safety requirements, regulatory mandates for sterile packaging, and sustainability needs are positively impacting the market. Advances in ophthalmic drug delivery systems, including controlled release technologies and specialized delivery solutions, are creating demand for sophisticated packaging that can maintain product efficacy and ensure patient compliance.

Restraint: High manufacturing costs due to stringent regulatory requirements and need for specialized materials

High manufacturing costs represent a significant restraint in the ophthalmic packaging market due to stringent regulatory requirements. The need for non-reactive packaging materials, cleanroom manufacturing conditions, and compliance with pharmaceutical packaging standards creates substantial cost pressures for manufacturers. These requirements, while essential for patient safety and product integrity, can limit market entry for smaller players and increase overall product costs.

Opportunity: Expanding personalized medicine and growth in emerging markets

The expanding field of personalized medicine and the growth of emerging markets present significant opportunities for the ophthalmic packaging market. As healthcare investments increase in regions like Asia Pacific, particularly in India and China, demand for advanced packaging solutions is rising. The development of customized treatment approaches and patient-specific formulations requires flexible, innovative packaging systems that can accommodate varying dosages and delivery methods.

Challenge: Ensuring packaging supports anti-counterfeit measures through advanced technologies

Ensuring that packaging supports the fight against counterfeit drugs through advanced anti-counterfeit technologies remains a key challenge for the ophthalmic packaging industry. Manufacturers must invest in sophisticated security features, track-and-trace systems, and tamper-evident designs while maintaining cost-effectiveness and ease of use. The implementation of these technologies requires ongoing investment in research and development and collaboration across the pharmaceutical supply chain.

OPHTHALMIC PACKAGING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides sustainable packaging solutions for ophthalmic pharmaceutical products, focusing on recyclable materials and innovative designs that maintain product sterility and integrity while reducing environmental impact Ensures product safety, supports sustainability goals, enhances brand reputation, and meets evolving regulatory requirements for pharmaceutical packaging
Supplies innovative closure systems and specialized glass containers for ophthalmic injectables and biologics, including the Gx Cap system designed for enhanced safety and ease of use in clinical settings Provides superior product protection, enables precise dosing, reduces contamination risk, and supports the safe delivery of sensitive ophthalmic formulations

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ophthalmic packaging market is a collaborative ecosystem where packaging manufacturers, pharmaceutical companies, material suppliers, regulatory bodies, and healthcare providers work together to develop and implement advanced packaging solutions for eye care products. Companies in the market supply a variety of packaging materials and systems, including plastic bottles, glass vials, specialized closures, and advanced delivery devices. Contract development and manufacturing organizations, research institutions, and testing laboratories support the development, validation, and scale-up processes for these packaging solutions. Collaboration between packaging companies and pharmaceutical firms is a critical strategy to enhance innovation and address regulatory challenges. Ultimately, healthcare institutions and patients benefit from packaging solutions that ensure product safety, maintain drug efficacy, and provide ease of use, supported by comprehensive regulatory frameworks and quality standards.

ophthalmic-packaging-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

ophthalmic-packaging-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Ophthalmic Packaging Market, by Material

The plastic material segment is leading the growth in the ophthalmic packaging market as it offers lightweight characteristics, cost-effective solutions, and flexible design options, which work for multidose eye drop bottles and single-dose vials. Plastics like polyethylene and polypropylene provide optimal compatibility with ophthalmic formulations while offering benefits in squeezability, durability, and break resistance, which glass does not provide. The pharmaceutical manufacturing industry is experiencing increased adoption of advanced polymer technologies with low extractables and leachables, high-purity grades, and sustainable recyclable plastic solutions.

Ophthalmic Packaging Market, by Product Type

The bottles segment is leading growth in the ophthalmic packaging market, driven by its extensive use in multi-dose eye drop delivery systems for both prescription and OTC applications. The rising need for chronic eye disease treatments drives growth as bottles provide users with convenient features that enable them to use the product multiple times at a lower cost. The implementation of preservative-free multidose bottle technologies has been enhanced through filter membrane and one-way valve system advancements, which improve product safety and sterility. Bottles have become the main choice for pharmaceutical manufacturers because of their ability to work with plastic materials and their simple handling and mass production capabilities.

Ophthalmic Packaging Market, by Dosage Form

The single-dose segment is leading growth in the ophthalmic packaging market, driven by increasing demand for preservative-free formulations and enhanced patient safety. Single-dose units eliminate the risk of contamination, which makes them highly suitable for sensitive eye treatments, post-surgical care, and biologics where sterility is critical. The market for this segment is experiencing growth due to increasing regulatory requirements for aseptic packaging and the implementation of blow-fill-seal BFS technology as a cost-effective method for large-scale production. The healthcare sector is experiencing a trend toward single-dose products as patients and providers become more aware of hygiene practices and accurate medication delivery in developed countries.

Ophthalmic Packaging Market, by Application

Injectables represented the largest segment of the ophthalmic packaging market due to their widespread use for vaccines and biologics requiring precise dosage and enhanced safety features. The increasing prevalence of chronic eye conditions requiring injectable treatments, combined with the growing adoption of biologic therapies, has propelled this segment to the forefront. Factors such as the need for sterile packaging, precise dose delivery, and compatibility with sensitive formulations are driving demand for specialized packaging solutions designed specifically for ophthalmic injectables.

REGION

Asia Pacific to be fastest-growing market during forecast period

The Asia Pacific region is the fastest-growing market for ophthalmic packaging, with the market size expected to reach USD 7.3 billion by 2030 at a CAGR of 18.0% from 2025 to 2030. This growth is driven by high healthcare investments and strong manufacturing capabilities in India and China. The increasing prevalence of eye-related disorders, expanding pharmaceutical manufacturing infrastructure, and rising healthcare expenditure across the region are creating substantial demand for advanced ophthalmic packaging solutions. Additionally, the growing middle-class population, improving access to healthcare services, and supportive government initiatives for pharmaceutical manufacturing are facilitating rapid market expansion in this region.

ophthalmic-packaging-market Region

OPHTHALMIC PACKAGING MARKET: COMPANY EVALUATION MATRIX

Amcor plc, recognized as a leading player in the ophthalmic packaging market, offers a diverse portfolio that includes sustainable packaging solutions, advanced polymer-based containers, and innovative designs for pharmaceutical applications. The company focuses on sustainability initiatives and has strengthened its market presence through strategic acquisitions, including the acquisition of Berry Global in 2023. Another significant player in the market is Gerresheimer AG, identified as a key innovator. The company is strengthening its position by introducing advanced closure systems, specialized glass containers, and innovative solutions, such as the Gx Cap, designed for enhanced safety and ease of use in ophthalmic applications.

ophthalmic-packaging-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value)  
Market Forecast in 2030 (Value) USD 21.9 Billion
Growth Rate CAGR of 15.5% from 2025-2030
Years Considered 2022-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Material (Plastic, Metal, Glass), Product Type (Bottles, Vials & Ampoules, Tubes, Syringes, Bags & Pouches), Dosage Form (Single-dose, Multi-dose), Application (Injectables, Eye Drops, Ointments & Gels, Other Ophthalmic Formulations)
Regions Covered North America, Europe, Asia Pacific, South America, and Middle East & Africa

WHAT IS IN IT FOR YOU: OPHTHALMIC PACKAGING MARKET REPORT CONTENT GUIDE

ophthalmic-packaging-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Understanding demand patterns for ophthalmic packaging across global pharmaceutical markets Assessed packaging usage trends across key regions, including North America, Europe, and Asia Pacific, highlighting differences in adoption of plastic bottles, glass vials, and specialized delivery systems across injectable, eye drop, and ointment applications Helps clients align product portfolios with region-specific demand drivers, regulatory requirements, and therapeutic trends
Identifying local manufacturing and sourcing opportunities Mapped regional packaging suppliers, contract manufacturers, and material providers across North America, Europe, and Asia Pacific, with insights into polymer processing, glass manufacturing, closure systems, and pharmaceutical-grade material supply Supports localization strategies, reduces supply-chain risk, lowers production costs, and improves speed-to-market

RECENT DEVELOPMENTS

  • July 2025 : AptarGroup launched a bio-based nasal spray pump, enhancing sustainability in pharmaceutical packaging and demonstrating the company's commitment to eco-friendly solutions that maintain high performance standards for drug delivery applications.
  • June 2024 : Schott AG announced a joint venture with Serum Institute of India to expand production capacities for pharmaceutical packaging, strengthening its presence in the rapidly growing Asia Pacific market and supporting increased demand for high-quality glass containers.
  • 2023 : Amcor acquired Berry Global to enhance its market presence and expand its portfolio of sustainable packaging solutions, positioning the company to better serve the growing demand for environmentally responsible pharmaceutical packaging.
  • 2025 : Gerresheimer completed a significant contract with a leading biotech firm to supply innovative closure systems designed for advanced ophthalmic formulations, demonstrating the company's capability to meet the evolving needs of pharmaceutical manufacturers.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
 
4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
 
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
 
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
5.2.3
TRENDS IN PACKAGING INDUSTRY
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND, BY TYPE (2022-2025)
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND OF OPHTHALMIC MATERIAL, BY KEY PLAYERS (2022-2025)
 
 
 
 
 
5.5.3
AVERAGE SELLING PRICE TREND, BY REGION (2022-2025)
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 390461)
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 390461)
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
5.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF – OPHTHALMIC PACKAGING MARKET
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
5.11.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
5.11.4.3
APAC
 
 
 
5.11.5IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
6.1.1
PRESERVATIVE-FREE MULTIDOSE OPHTHALMIC DELIVERY SYSTEMS
 
 
 
 
 
6.1.2
BLOW-FILL-SEAL (BFS) SINGLE-DOSE PACKAGING ADVANCEMENTS
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
6.2.1
ASEPTIC MANUFACTURING & FILL-FINISH TECHNOLOGIES
 
 
 
 
 
6.2.2
ERGONOMIC DISPENSING DESIGN & MICRO-DOSING CONTROL
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
6.3.1
SMART PACKAGING & COMPLIANCE MONITORING (CONNECTED DEVICES)
 
 
 
 
 
6.3.2
ADVANCED POLYMER MATERIALS (LOW EXTRACTABLES/LEACHABLES)
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON OPHTHALMIC PACKAGING MARKET
 
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
6.6.2
BEST PRACTICES IN OPHTHALMIC PACKAGING MANUFACTURERS
 
 
 
 
 
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN OPHTHALMIC PACKAGING MARKET
 
 
 
 
 
6.6.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT AI IN OPHTHALMIC PACKAGING MARKET
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
 
8.1
INTRODUCTION
 
 
 
 
 
8.2
DECISION-MAKING PROCESS
 
 
 
 
 
8.3
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
 
 
 
 
 
 
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
8.3.2
BUYING CRITERIA
 
 
 
 
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
8.6
MARKET PROFITABILITY
 
 
 
 
9
OPHTHALMIC PACKAGING MARKET, BY MATERIAL (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION & VOLUME, KILOTON)
 
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY MATERIALS, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS
 
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
 
9.2
PLASTIC
 
 
 
 
 
9.3
METAL
 
 
 
 
 
9.3
GLASS
 
 
 
 
10
OPHTHALMIC PACKAGING MARKET, BY PRODUCT TYPE (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION & VOLUME, KILOTON)
 
 
 
 
 
 
ANALYSIS OF REQUIREMENT OF OPHTHALMIC PACKAGING IN VARIOUS PRODUCT TYPES
 
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
 
10.2
BOTTLES
 
 
 
 
 
10.3
VIALS & AMPOULES
 
 
 
 
 
10.4
TUBES
 
 
 
 
 
10.5
SYRINGES
 
 
 
 
 
10.6
BAGS & POUCHES
 
 
 
 
 
10.7
OTHERS
 
 
 
 
11
OPHTHALMIC PACKAGING MARKET, BY DOSAGE FORM (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION & VOLUME, KILOTON)
 
 
 
 
 
 
DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING OPHTHALMIC PACKAGING ADOPTION IN DIVERSE FORMS
 
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
 
11.2
SINGLE-DOSE
 
 
 
 
 
11.3
MULTI-DOSE
 
 
 
 
12
OPHTHALMIC PACKAGING MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION & VOLUME, KILOTON)
 
 
 
 
 
 
DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING OPHTHALMIC PACKAGING ADOPTION IN DIVERSE APPLICATIONS
 
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
 
12.2
INJECTABLES
 
 
 
 
 
12.3
EYE DROPS
 
 
 
 
 
12.4
OINTMENTS & GELS
 
 
 
 
 
12.5
OTHER OPHTHALMIC FORMULATIONS
 
 
 
 
13
OPHTHALMIC PACKAGING MARKET, BY REGION (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION & VOLUME, KILOTON)
 
 
 
 
 
 
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
 
 
 
 
 
 
13.1
INTRODUCTION
 
 
 
 
 
13.2
ASIA PACIFIC
 
 
 
 
 
 
13.2.1
CHINA
 
 
 
 
 
13.2.2
JAPAN
 
 
 
 
 
13.2.3
INDIA
 
 
 
 
 
13.2.4
SOUTH KOREA
 
 
 
 
 
13.2.5
REST OF ASIA PACIFIC
 
 
 
 
13.3
NORTH AMERICA
 
 
 
 
 
 
13.3.1
US
 
 
 
 
 
13.3.2
CANADA
 
 
 
 
 
13.3.3
MEXICO
 
 
 
 
13.4
EUROPE
 
 
 
 
 
 
13.4.1
GERMANY
 
 
 
 
 
13.4.2
FRANCE
 
 
 
 
 
13.4.3
UK
 
 
 
 
 
13.4.4
ITALY
 
 
 
 
 
13.4.5
SPAIN
 
 
 
 
 
13.4.6
REST OF EUROPE
 
 
 
 
13.5
SOUTH AMERICA
 
 
 
 
 
 
13.5.1
BRAZIL
 
 
 
 
 
13.5.2
ARGENTINA
 
 
 
 
 
13.5.3
REST OF SOUTH AMERICA
 
 
 
 
13.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
13.6.1
GCC COUNTRIES
 
 
 
 
 
 
13.6.1.1
SAUDI ARABIA
 
 
 
 
 
13.6.1.2
REST OF GCC COUNTRIES
 
 
 
 
13.6.2
SOUTH AFRICA
 
 
 
 
 
13.6.3
REST OF MIDDLE EAST & AFRICA
 
 
 
14
COMPETITIVE LANDSCAPE
 
 
 
 
 
 
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
 
 
 
 
 
 
 
14.1
OVERVIEW
 
 
 
 
 
14.2
KEY PLAYERS’ STRATEGIES/RIGHT TO WIN (2021–2025)
 
 
 
 
 
14.3
REVENUE ANALYSIS (2022-2024)
 
 
 
 
 
 
14.4
MARKET SHARE ANALYSIS (2024)
 
 
 
 
 
 
14.5
PRODUCT COMPARISON
 
 
 
 
 
 
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
 
14.6.1
STARS
 
 
 
 
 
14.6.2
EMERGING LEADERS
 
 
 
 
 
14.6.3
PERVASIVE PLAYERS
 
 
 
 
 
14.6.4
PARTICIPANTS
 
 
 
 
 
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
 
14.6.5.1
COMPANY FOOTPRINT
 
 
 
 
 
14.6.5.2
REGION FOOTPRINT
 
 
 
 
 
14.6.5.3
MATERIAL FOOTPRINT
 
 
 
 
 
14.6.5.4
PRODUCT TYPE FOOTPRINT
 
 
 
 
 
14.6.5.5
DOSAGE FORM FOOTPRINT
 
 
 
 
 
14.6.5.6
APPLICATION FOOTPRINT
 
 
 
14.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
 
14.7.1
PROGRESSIVE COMPANIES
 
 
 
 
 
14.7.2
RESPONSIVE COMPANIES
 
 
 
 
 
14.7.3
DYNAMIC COMPANIES
 
 
 
 
 
14.7.4
STARTING BLOCKS
 
 
 
 
 
14.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
 
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
14.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
14.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
14.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
14.9.1
PRODUCT LAUNCHES
 
 
 
 
 
14.9.2
DEALS
 
 
 
 
 
14.9.3
EXPANSIONS
 
 
 
15
COMPANY PROFILES
 
 
 
 
 
 
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE OPHTHALMIC PACKAGING MARKET LANDSCAPE
 
 
 
 
 
 
15.1
KEY PLAYERS
 
 
 
 
 
 
15.1.1
APTARGROUP
 
 
 
 
 
 
15.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.1.4
MNM VIEW
 
 
 
 
 
 
15.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
15.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
15.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
15.1.2
GERRESHEIMER AG
 
 
 
 
 
 
15.1.2.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.2.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.2.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.2.4
MNM VIEW
 
 
 
 
15.1.3
WEST PHARMACEUTICAL SERVICES
 
 
 
 
 
 
15.1.3.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.3.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.3.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.3.4
MNM VIEW
 
 
 
 
15.1.4
AMCOR
 
 
 
 
 
 
15.1.4.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.4.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.4.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.4.4
MNM VIEW
 
 
 
 
15.1.5
SCHOTT
 
 
 
 
 
 
15.1.5.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.5.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.5.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.5.4
MNM VIEW
 
 
 
 
15.1.6
NOLATO
 
 
 
 
 
 
15.1.6.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.6.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.7.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.6.4
MNM VIEW
 
 
 
 
15.1.7
CATALENT
 
 
 
 
 
 
15.1.7.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.7.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.7.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.7.4
MNM VIEW
 
 
 
 
15.1.8
NEMERA
 
 
 
 
 
 
15.1.8.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.8.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.8.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.8.4
MNM VIEW
 
 
 
 
15.1.9
BORMIOLI PHARMA S.P.A.
 
 
 
 
 
 
15.1.9.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.9.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.9.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.9.4
MNM VIEW
 
 
 
 
15.1.10
STEVANATO GROUP
 
 
 
 
 
 
15.1.10.1
BUSINESS OVERVIEW
 
 
 
 
 
15.1.10.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
15.1.10.3
RECENT DEVELOPMENTS
 
 
 
 
 
15.1.10.4
MNM VIEW
 
 
 
15.2
OTHER PLAYERS
 
 
 
 
16
RESEARCH METHODOLOGY
 
 
 
 
 
 
16.1
RESEARCH DATA
 
 
 
 
 
 
16.1.1
SECONDARY DATA
 
 
 
 
 
 
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
16.1.1.2
LIST OF KEY SECONDARY SOURCES
 
 
 
 
16.1.2
PRIMARY DATA
 
 
 
 
 
 
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
16.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
16.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
16.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
16.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
16.2.2
TOP-DOWN APPROACH
 
 
 
 
 
16.2.3
MARKET SIZE CALCULATION FOR BASE YEAR
 
 
 
 
16.3
MARKET FORECAST APPROACH
 
 
 
 
 
 
16.3.1
SUPPLY SIDE
 
 
 
 
 
16.3.2
DEMAND SIDE
 
 
 
 
16.4
DATA TRIANGULATION
 
 
 
 
 
16.5
FACTOR ANALYSIS
 
 
 
 
 
16.6
RESEARCH ASSUMPTIONS AND LIMITATIONS
 
 
 
 
 
16.7
RISK ASSESSMENT
 
 
 
 
17
APPENDIX
 
 
 
 
 
 
17.1
DISCUSSION GUIDE
 
 
 
 
 
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
17.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
17.4
RELATED REPORTS
 
 
 
 
 
17.5
AUTHOR DETAILS
 
 
 
 

Methodology

The study involved four major activities to estimate the current size of the Ophthalmic Packaging Market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of pharmaceutical packaging through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the Ophthalmic Packaging Market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for the companies offering pharmaceutical packaging is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to in order to identify and collect information for this study on the Ophthalmic Packaging Market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the Ophthalmic Packaging Market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of pharmaceutical packaging offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate and validate the size of the Ophthalmic Packaging Market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

Ophthalmic Packaging Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Pharmaceutical packaging pertains to the materials and systems designed to protect, preserve, and deliver pharmaceutical products for oral, injectable, inhalation, and topical drug delivery modalities. It plays an important role in the stability and sterility of a drug, avoids contamination, and provides accurate dosing for the life of the product. Pharmaceutical packaging denotes the numerous varieties of available options, like plastic bottles, blister packs, vials, ampoules, prefillable syringes, tubes, pouches, and cartons to meet drug formulation requirements and regulatory obligations. Some of the significant functionalities of pharmaceutical packaging include moisture, oxygen, and light barrier protection, tamper evidence, patient convenience, and functionality with active pharmaceutical ingredients (APIs).

Areas of interest include ISO 15378 relating specifically to primary packaging materials, ISO 9001 regarding quality management systems, and GMP compliance. The DSCSA and the EU FMD identified serialized, tracking, and anti-counterfeiting programs, creating an opportunity for the packaging industry to help with drug quality and patient safety.

Stakeholders

  • Pharmaceutical packaging manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the Ophthalmic Packaging Market, based  on type, packaging type, drug delivery, raw material, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, product launches, expansions, partnerships, and agreements in the Ophthalmic Packaging Market
  • To provide the impact of AI/Gen AI on the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to client-specific needs.

The following customization options are available for the Ophthalmic Packaging Market report:

Product Analysis

  • A product matrix that gives a detailed comparison of the product portfolio of each company

Geographic Analysis as per Feasibility

  • A further breakdown of the Ophthalmic Packaging Market for additional countries

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

 

Growth Signals

See competitors, opportunities & growth signals

Explore Intelligence

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Ophthalmic Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Ophthalmic Packaging Market

What the Report Didn't Show You? Turn research into consulting-grade strategic intelligence.
15+ outputs | Interactive dashboards | Proprietary data
Explore with GrowthIQ →
DMCA.com Protection Status